Abstract
Background
The extracellular matrix (ECM) is characterized by not only well-preserved scaffolds of organs and vascularized tissues, but also by extremely low immunogenicity during allo- or xeno-implantation. This study aimed to establish a model of a composite microvasculature network scaffold with a small-caliber-dominant vascular pedicle by decellularizing fetal porcine aorta and the conterminous mesentery.
Methods
The aorta and the conterminous mesenteric vascular system originating from the inferior mesenteric artery were harvested from fetal pigs at late gestation. All of the cellular components were removed by sequential treatment with Triton X-100 and sodium dodecyl sulfate. After the degree of decellularization was assessed, the fetal porcine aorta and mesenteric acellular matrix (FPAMAM) were transplanted into dogs.
Results
Gross and histologic examination demonstrated the removal of cellular constituents with preservation of ECM architecture, including macrochannels and microchannels. The residual DNA content in the FPAMAM was less than 2 %. The aorta and microchannels were perfused well, and the fetal porcine aorta had good patency for more than 3 months.
Conclusions
The integrity of the FPAMAM provided a scaffold for the reconstruction of a rich vascular network with numerous segmentally radiating branches. Decellularized fetal porcine vascular tissue might be a potential alternative for xenogeneic transplantation based on its optimized properties and low immunogenicity.
Level of Evidence II
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Similar content being viewed by others
References
Vincenzo V, Cortivo R, Lacobellis L et al (2009) Hyaluronan benzyl ester as a scaffold for tissue engineering. Int J Mol Sci 10:2972–2985
Baguneid MS, Seifalian AM, Salacinski HJ et al (2006) Tissue engineering of blood vessels. Br J Surg 93:282–290
Chang EI, Bonillas RG, El-ftesi S et al (2009) Tissue engineering using autologous microcirculatory beds as vascularized bioscaffolds. FASEB J 23:906–915
Tu JV, Pashos CL, Naylor CD et al (1997) Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med 337:139
Stegemann JP, Kaszuba SN, Rowe SL (2007) Review: advances in vascular tissue engineering using protein-based biomaterials. Tissue Eng 13:2601–2613
Kulig KM, Vacanti JP (2004) Hepatic tissue engineering. Transpl Immunol 12:303–310
Nahmias Y, Schwartz RE, Hu WS et al (2006) Endothelium mediated hepatocyte recruitment in the establishment of liver-like tissue in vitro. Tissue Eng 12:1627–1638
Griffith LG, Naughton G (2002) Tissue engineering - current challenges and expanding opportunities. Science 295:1009–1014
Folkman J, Hochberg M (1973) Self-regulation of growth in three dimensions. J Exp Med 138:745–753
Baptista PM, Siddiqui MM, Lozier G et al (2011) The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology 53:604–617
Uygun BE, Soto-Gutierrez A, Yagi H et al (2010) Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 16:814–820
Schaner PJ, Martin ND, Tulenko TN et al (2004) Decellularized vein as a potential scaffold for vascular tissue engineering. J Vasc Surg 40:146–153
Gilbert TW, Freund JM, Badylak SF (2009) Quantification of DNA in biologic scaffold materials. J Surg Res 152:135–139
Giessler GA, Friedrich PF, Shin RH et al (2007) The superficial inferior epigastric artery fascia flap in the rabbit. Microsurgery 27:560–564
Allaire E, Bruneval P, Mandet C et al (1997) The immunogenicity of the extracellular matrix in arterial xenografts. Surgery 122:73–81
Eventov-Friedman S, Katchman H, Shezen E et al (2005) Embryonic pig liver, pancreas, and lung as a source for transplantation: optimal organogenesis without teratoma depends on distinct time windows. Proc Natl Acad Sci USA 102:2928–2933
Dekel B, Burakova T, Arditti FD et al (2003) Human and porcine early kidney precursors as a new source for transplantation. Nat Med 9:53–60
Teebken OE, Bader A, Steinhoff G et al (2000) Tissue engineering of vascular grafts: human cell seeding of decellularised porcine matrix. Eur J Vasc Endovasc Surg 19:381–386
Badylak SF (2004) Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl Immunol 12:367–377
Badylak SF (2007) The extracellular matrix as a biologic scaffold material. Biomaterials 28:3587–3593
Dahl SL, Koh J, Prabhakar V et al (2003) Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant 12:659–666
Ott HC, Matthiesen TS, Goh SK et al (2008) Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat Med 14:213–221
Gilbert TW, Sellaro TL, Badylak SF (2006) Decellularization of tissues and organs. Biomaterials 27:3675–3683
Samouillan V, Dandurand-Lods J, Lamure A et al (1999) Thermal analysis characterization of aortic tissues for cardiac valve bioprostheses. J Biomed Mater Res 46:531–538
Cho SW, Park HJ, Ryu JH et al (2005) Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matrices. Biomaterials 26:1915–1924
Amiel GE, Komura M, Shapira O et al (2006) Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells. Tissue Eng 12:2355–2365
Hoganson DM, Owens GE, O’Doherty EM et al (2010) Preserved extracellular matrix components and retained biological activity in decellularized porcine mesothelium. Biomaterials 31:6934–6940
Yayon A, Klagsbrun M, Esko JD et al (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841–848
Pike DB, Cai S, Pomraning KR et al (2006) Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 27:5242–5251
Elia R, Fuegy PW, VanDelden A et al (2010) Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factorloaded, glycosaminoglycan hydrogels. Biomaterials 31:4630–4638
Ballyk PD, Walsh C, Butany J et al (1998) Compliance mismatch may promote graft-artery intimal hyperplasia by altering suture-line stresses. J Biomech 31:229–237
Glotzbach JP, Levi B, Wong VW et al (2010) The basic science of vascular biology: implications for the practicing surgeon. Plast Reconstr Surg 126:1528–1538
Kelly BD, Hackett SF, Hirota K et al (2003) Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93:1074–1081
Van Royen N, Piek JJ, Buschmann I et al (2001) Stimulation of arteriogenesis: a new concept for the treatment of arterial occlusive disease. Cardiovasc Res 49:543–553
Acknowledgments
This work was supported by the National Science Foundation of China (Grant No. 81171825).
Disclosures
The authors have no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary material 1 (MP4 11,528 kb)
Supplementary material 2 (MP4 4,516 kb)
Rights and permissions
About this article
Cite this article
Li, Q., Huang, C., Xu, Z. et al. The Fetal Porcine Aorta and Mesenteric Acellular Matrix as Small-caliber Tissue Engineering Vessels and Microvasculature Scaffold. Aesth Plast Surg 37, 822–832 (2013). https://doi.org/10.1007/s00266-013-0173-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-013-0173-6